GSKPDUFA
Zidesamtinib (NVL-520)
TKI Pre-treated Patients with Advanced ROS1-positive NSCLC
Approval decisionFDA regulatory calendar
Track FDA action dates and advisory committee meetings by month. Each event links to its company, drug, indication and source-backed research record.
Use the monthly FDA calendar to review PDUFA target dates and advisory committee meetings, then open each event for drug, company, indication and source context.